PalOctPGMS: Difference between revisions
From Bioblast
(Created page with "{{MitoPedia |abbr=PalOctPGMS |description='''PalOctPGMS''': Palmitoylcarnitine & Octanoylcarnitine & Pyruvate & Glutamate & Malate & Succinate. '''Mit...") |
Beno Marija (talk | contribs) No edit summary |
||
| Line 14: | Line 14: | ||
::::» [[Fatty acid oxidation pathway control state]] | ::::» [[Fatty acid oxidation pathway control state]] | ||
::::» [[FN]] | ::::» [[FN]] | ||
::::» [[NADH | ::::» [[NADH electron transfer-pathway state]] | ||
::::» [[FNS]] | ::::» [[FNS]] | ||
Latest revision as of 14:36, 26 August 2020
- high-resolution terminology - matching measurements at high-resolution
PalOctPGMS
Description
PalOctPGMS: Palmitoylcarnitine & Octanoylcarnitine & Pyruvate & Glutamate & Malate & Succinate.
MitoPathway control state: FNS
SUIT protocols: SUIT-019
Abbreviation: PalOctPGMS
Reference: SUIT reference protocol
MitoPedia concepts:
SUIT state
- More details
PalOctPGMSL
PalOctPGMS in the LEAK state can be evaluated in the following SUIT protocols:
PalOctPGMSP
PalOctPGMS in the OXPHOS state can be evaluated in the following SUIT protocols:
PalOctPGMSE
PalOctPGMS in the ET state can be evaluated in the following SUIT protocols:
